Novel Methods of Targeting IL-1 Signalling for the Treatment of Breast Cancer Bone Metastasis

Novel Methods of Targeting IL-1 Signalling for the Treatment of Breast Cancer Bone Metastasis

Breast cancer bone metastasis is currently incurable. Evidence suggests that inhibiting IL-1 signalling with the IL1R antagonist, Anakinra, or the IL1β antibody, Canakinumab, prevents metastasis and almost eliminates breast cancer growth in the bone. However, these drugs increase primary tumour grow...

Full description

Bibliographic Details
Main Authors: Jiabao Zhou, Jennifer M. Down, Christopher N. George, Jessica Murphy, Diane V. Lefley, Claudia Tulotta, Marwa A. Alsharif, Michael Leach, Penelope D. Ottewell
Format: Article
Language:English
Published: MDPI AG 2022-10-01
Series:Cancers
Subjects:
breast cancer
bone metastasis
IL1β
mouse models
Online Access:https://www.mdpi.com/2072-6694/14/19/4816

Internet

https://www.mdpi.com/2072-6694/14/19/4816

Similar Items